Oppenheimer Believes LHC Group (LHCG) Won’t Stop Here


In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on LHC Group (LHCG). The company’s shares opened today at $113.51, close to its 52-week high of $114.22.

According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 14.4% and a 66.4% success rate. Wiederhorn covers the Services sector, focusing on stocks such as Cross Country Healthcare, Addus Homecare Corp, and Community Health.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for LHC Group with a $121 average price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $114.22 and a one-year low of $59.21. Currently, LHC Group has an average volume of 261.6K.

Based on the recent corporate insider activity of 53 insiders, corporate insider sentiment is neutral on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts